Celecoxib

Product manufactured by Direct_rx

Application Nr Approved Date Route Status External Links
ANDA204590 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Warning: Risk Of Serious Cardiovascular And Gastrointestinal Events Cardiovascular Thrombotic Events • Nonsteroidal Anti-Inflammatory Drugs (Nsaids) Cause An Increased Risk Of Serious Cardiovascular Thrombotic Events, Including Myocardial Infarction, And Stroke, Which Can Be Fatal. This Risk May Occur Early In The Treatment And May Increase With Duration Of Use. [See Warnings And Precautions (5.1)] • Celecoxib Capsules Are Contraindicated In The Setting Of Coronary Artery Bypass Graft (Cabg) Surgery. [See Contraindications (4) And Warnings And Precautions (5.1)] Gastrointestinal Bleeding, Ulceration, And Perforation • Nsaids Cause An Increased Risk Of Serious Gastrointestinal (Gi) Adverse Events Including Bleeding, Ulceration, And Perforation Of The Stomach Or Intestines, Which Can Be Fatal. These Events Can Occur At Any Time During Use And Without Warning Symptoms. Elderly Patients And Patients With A Prior History Of Peptic Ulcer Disease And/or Gi Bleeding Are At Greater Risk For Serious Gi Events. [See Warnings And Precautions (5.2)]

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Celecoxib CELECOXIB ZINC2570895

Comments